Alzheimer's

Researchers at St. Michael's College discovered a potential breakthrough in Alzheimer's treatment by examining the inner workings of spider brains.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

We learn about what happens when younger people are diagnosed with what’s often thought of as an older person’s disease: Alzheimer's.

Researchers launched a major study of an experimental Alzheimer's drug this summer. They also learned a lot about how to protect participants who must make frequent visits to a medical center.

After a decade of failure in treating Alzheimer's with drugs, the National Institutes of Health is funding a five-year effort in Seattle to learn more about how the disease starts in the brain.

Scientists are gaining insights into why Alzheimer's is more common in women. The answer involves genetics, hormones and sex-related brain differences.

For individuals with dementia, in most cases there is at least one caregiver who is helping them navigate life with memory loss. We look at the challenges…

Alzheimer's affects 11,000 Vermonters. But that is only part of the picture. There are also 30,000 family caregivers for those suffering from the…